CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV).

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Vaccine

• Publication date

  2007-04-30

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/J.VACCINE.2006.12.052PMID 17257713
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterisation of the discrepancy between PCR and virus isolation in relation to classical swine fever virus detection.

  2006cited by this paper
• Immunological properties of recombinant classical swine fever virus NS3 protein in vitro and in vivo.

  2006cited by this paper
• Virus taxonomy : eighth report of the International Committee on Taxonomy of Viruses

  2005cited by this paper
• Nachweis und Spezies-spezifische Differenzierung von Pestiviren mit der real-time RT-PCR

  2005cited by this paper
• Pestiviruses isolated from pigs, cattle and sheep can be allocated into at least three genogroups using polymerase chain reaction and restriction endonuclease analysis

  2005cited by this paper
• [Detection and species-specific differentiation of pestiviruses using real-time RT-PCR].

  2005cited by this paper
• Validation of a real-time RT-PCR assay for sensitive and specific detection of classical swine fever.

  2005cited by this paper
• Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV.

  2005cited by this paper
• An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus.

  2004cited by this paper
• Protection of pigs against 'in contact' challenge with classical swine fever following oral or subcutaneous vaccination with a recombinant porcine adenovirus.

  2003cited by this paper
• Evaluation of the oral immunisation of wild boar against classical swine fever in Baden-Württemberg.

  2003cited by this paper
• Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV.

  2002cited by this paper
• Oral immunisation of wild boar against classical swine fever: concluding analysis of the recent field trials in Germany.

  2002cited by this paper
• Prevalence of antibodies to classical swine fever, Aujeszky's disease, porcine reproductive and respiratory syndrome, and bovine viral diarrhoea viruses in wild boars in Croatia.

  2002cited by this paper
• Classical swine fever (hog cholera) in wild boar in Europe.

  2002cited by this paper
• Molecular epidemiology of classical swine fever in Italy.

  2001cited by this paper
• [Detection of infection with classical swine fever virus in wild boar: a comparison of different laboratory diagnostic methods].

  2001cited by this paper
• Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs.

  2001cited by this paper
• Classical swine fever (CSF) marker vaccine. Trial III. Evaluation of discriminatory ELISAs.

  2001cited by this paper
• Oral immunisation against classical swine fever (CSF): onset and duration of immunity.

  2001cited by this paper
• Localization of viral proteins in cells infected with bovine viral diarrhoea virus.

  2001cited by this paper
• Classical swine fever: the global situation.

  2000cited by this paper
• Prevention of transplacental transmission of moderatevirulent classical swine fever virus after single or double vaccination with an e2 subunit vaccine

  2000cited by this paper
• Classical Swine Fever Virus ErnsDeletion Mutants: trans-Complementation and Potential Use as Nontransmissible, Modified, Live-Attenuated Marker Vaccines

  2000cited by this paper
• Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response.

  2000cited by this paper
• Incidence and control of CSF in wild boar in Europe.

  2000cited by this paper
• Classical swine fever: the European experience and a guide for infected areas.

  1999cited by this paper
• An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV).

  1999cited by this paper
• Closed one-tube reverse transcription nested polymerase chain reaction for the detection of pestiviral RNA with fluorescent probes.

  1999cited by this paper
• Recovery of cytopathogenic and noncytopathogenic bovine viral diarrhea viruses from cDNA constructs

  1996cited by this paper
• Classical swine fever in wild boar (Sus scrofa)--experimental infections and viral persistence.

  1995cited by this paper
• Epidemiology of classical swine fever in Sardinia: a serological survey of wild boar and comparison with African swine fever

  1994cited by this paper
• Characterization and pathogenicity for pigs of a hog cholera virus strain isolated from wild boars.

  1992cited by this paper
• The protective value of vaccine-induced neutralising antibody titres in swine fever.

  1988cited by this paper
• Restraint and handling of wild and domestic animals

  1980cited by this paper

• Protective Efficacy of a Chimeric Pestivirus KD26_E2LOM Vaccine Against Classical Swine Fever Virus Infection of Pigs

  2025cites this paper
• Self-Replicating RNA Derived from the Genomes of Positive-Strand RNA Viruses.

  2024cites this paper
• Identification of novel monoclonal antibodies specific for the conserved epitopes in the E2 protein of genotype 2 classical swine fever virus: implication for differential diagnosis

  2023cites this paper
• Quantitative analysis of viremia and viral shedding in pigs infected experimentally with classical swine fever virus isolates obtained from recent outbreaks in Japan

  2023cites this paper
• Different Types of Vaccines against Pestiviral Infections: “Barriers” for “Pestis”

  2022cites this paper
• Research Progress and Challenges in Vaccine Development against Classical Swine Fever Virus

  2021cites this paper
• Novel Vaccine Technologies in Veterinary Medicine: A Herald to Human Medicine Vaccines

  2021cites this paper
• A Critical Review about Different Vaccines against Classical Swine Fever Virus and Their Repercussions in Endemic Regions

  2021cites this paper
• Classic Swine Fever

  2021cites this paper
• Assessment of the control measures of the category A diseases of Animal Health Law: Classical Swine Fever

  2021cites this paper
• Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase

  2020cites this paper
• Genetically distinct pestiviruses pave the way to improved classical swine fever marker vaccine candidates based on the chimeric pestivirus concept

  2020cites this paper
• Assessment of the efficacy of an attenuated live marker classical swine fever vaccine (Flc-LOM-BErns) in pregnant sows.

  2019cites this paper
• Classical swine fever virus C-strain with eight mutation sites shows enhanced cell adaptation and protects pigs from lethal challenge

  2019cites this paper
• Expression of Immunodominant Regions of E2 from an Indian Isolate of Classical Swine Fever Virus

  2019cites this paper
• Chapter 2 Self-Replicating RNA

  2018cites this paper
• Recent Advances in Veterinary Diagnostic Virology

  2018cites this paper
• Population Dynamics Meets Animal Ethics: The Case for Aiding Animals in Nature

  2017cites this paper
• Classical swine fever vaccines-State-of-the-art.

  2017cites this paper
• A decade of research into classical swine fever marker vaccine CP7_E2alf (Suvaxyn® CSF Marker): a review of vaccine properties

  2017cites this paper
• Classical Swine Fever—An Updated Review

  2017cites this paper
• Potential of DIVA vaccines for Fish

  2016cites this paper
• Self-Replicating RNA

  2016cites this paper
• RNA-based viral vectors

  2015cites this paper
• Classical swine fever virus marker vaccine strain CP7_E2alf: genetic stability in vitro and in vivo

  2015cites this paper
• The Molecular Biology of Pestiviruses.

  2015cites this paper
• Genotyping of classical swine fever virus using high-resolution melt analysis.

  2015cites this paper
• Efficacy of CSF vaccine CP7_E2alf in piglets with maternally derived antibodies.

  2014cites this paper
• Cytokine and immunoglobulin isotype profiles during CP7_E2alf vaccination against a challenge with the highly virulent Koslov strain of classical swine fever virus.

  2014cites this paper
• Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes.

  2014cites this paper
• Classical swine fever in China: a minireview.

  2014cites this paper
• Differentiation of Classical Swine Fever Virus Infection from CP7_E2alf Marker Vaccination by a Multiplex Microsphere Immunoassay

  2014cites this paper
• First assessment of classical swine fever marker vaccine candidate CP7_E2alf for oral immunization of wild boar under field conditions.

  2014cites this paper
• Materials and methods Partners in the collaborative survey and evaluation of classical swine fever virus antibody enzyme-linked immunosorbent assays

  2013cites this paper
• Third generation DIVA vaccine towards classical swine fever virus. Efficacy in face of maternal immunity

  2013cites this paper
• Proteome-Wide Screening Reveals Immunodominance in the CD8 T Cell Response against Classical Swine Fever Virus with Antigen-Specificity Dependent on MHC Class I Haplotype Expression

  2013cites this paper
• CP7_E2alf oral vaccination confers partial protection against early classical swine fever virus challenge and interferes with pathogeny-related cytokine responses

  2013cites this paper
• [Progress in new-type vaccines against classical swine fever].

  2013cites this paper
• [Possibilities and limitations in veterinary vaccine development using the example of classical swine fever].

  2013cites this paper
• Approaches to DIVA vaccination for fish using infectious salmon anaemia and koi herpesvirus disease as models

  2013cites this paper
• Third generation DIVA vaccine towards classical swine fever virus. Efficacy in face of maternal immunity

  2013cites this paper
• Comprehensive evaluation of the adenovirus/alphavirus-replicon chimeric vector-based vaccine rAdV-SFV-E2 against classical swine fever.

  2013cites this paper
• Pig movements across eastern Indonesia and associated risk of classical swine fever transmission

  2012cites this paper
• Recent Advances in Veterinary Diagnostic Virology: Report from a Collaborating Centre of the World Organization for Animal Health (OIE)

  2012cites this paper
• NAHEMS Guidelines: Vaccination for Contagious Diseases, Appendix B: Vaccination for Classical Swine Fever

  2012cites this paper
• Construction of chimeric bovine viral diarrhea viruses containing glycoprotein E rns of heterologous pestiviruses and evaluation of the chimeras as potential marker vaccines against BVDV.

  2012cites this paper
• Efficacy of marker vaccine candidate CP7_E2alf in piglets with maternally derived C-strain antibodies.

  2012cites this paper
• Improved strategy for phylogenetic analysis of classical swine fever virus based on full-length E2 encoding sequences

  2012cites this paper
• Towards licensing of CP7_E2alf as marker vaccine against classical swine fever-Duration of immunity.

  2012cites this paper
• Evaluation of classical swine fever virus antibody detection assays with an emphasis on the differentiation of infected from vaccinated animals.

  2012cites this paper
• Characterisation of vaccine-induced, broadly cross-reactive IFN-γ secreting T cell responses that correlate with rapid protection against classical swine fever virus.

  2012cites this paper
• New insights into the antigenic structure of the glycoprotein E(rns) of classical swine fever virus by epitope mapping.

  2012cites this paper
• Protective efficacy of a Classical swine fever virus C-strain deletion mutant and ability to differentiate infected from vaccinated animals.

  2011cites this paper
• Innocuousness and safety of classical swine fever marker vaccine candidate CP7_E2alf in non-target and target species.

  2011cites this paper
• A generic real-time TaqMan assay for specific detection of lapinized Chinese vaccines against classical swine fever.

  2011cites this paper
• Classical swine fever: comparison of oronasal immunisation with CP7E2alf marker and C-strain vaccines in domestic pigs.

  2010influential citation
• An update on safety studies on the attenuated "RIEMSER Schweinepestoralvakzine" for vaccination of wild boar against classical swine fever.

  2010cites this paper
• Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza

  2010cites this paper
• Characterization of recombinant BVDV-2 vaccine prototypes based on packaged replicons and replication competent deletion mutants

  2010cites this paper
• Characterization of a new chimeric marker vaccine candidate with a mutated antigenic E2-epitope.

  2010cites this paper
• Application of marker vaccines against livestock diseases.

  2010cites this paper
• Rational design of a classical swine fever C-strain vaccine virus that enables the differentiation between infected and vaccinated animals.

  2010cites this paper
• Two real-time RT-PCR assays of classical swine fever virus, developed for the genetic differentiation of naturally infected from vaccinated wild boars.

  2009cites this paper
• Differentiation of C-strain "Riems" or CP7_E2alf vaccinated animals from animals infected by classical swine fever virus field strains using real-time RT-PCR.

  2009cites this paper
• Seroprevalence and risk factors for the presence of ruminant pestiviruses in the Dutch swine population.

  2009cites this paper
• Evaluation of baits for oral vaccination of European wild boar piglets.

  2009cites this paper
• Yeast-expressed classical swine fever virus glycoprotein E2 induces a protective immune response.

  2009cites this paper
• Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization.

  2009cites this paper
• Emerging animal diseases: from science to policy

  2008cites this paper